Cargando…
Favipiravir treatment does not influence disease progression among adult patients hospitalized with moderate-to-severe COVID-19: a prospective, sequential cohort study from Hungary
Data suggests that favipiravir (FVP) could be used against SARS-CoV-2. Our aim was to investigate the role of FVP in COVID-19 treatment. A prospective sequential cohort study was performed among adults hospitalized at our center between March and August 2020 with moderate-to-severe, PCR-confirmed CO...
Autores principales: | Szabo, Balint Gergely, Lenart, Katalin Szidonia, Petrik, Borisz, Gaspar, Zsofia, Kiss-Dala, Noemi, Szlavik, Janos, Valyi-Nagy, Istvan, Lakatos, Botond |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413073/ https://www.ncbi.nlm.nih.gov/pubmed/34476717 http://dx.doi.org/10.1007/s11357-021-00452-9 |
Ejemplares similares
-
Use of convalescent plasma therapy in hospitalised adult patients with non-critical COVID-19: a focus on the elderly from Hungary
por: Kiss-Dala, Noemi, et al.
Publicado: (2022) -
Outcomes of high-risk adult outpatients treated with early remdesivir therapy during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) omicron era: experiences from the national centre of Hungary
por: Gáspár, Zsófia, et al.
Publicado: (2023) -
Invasive fungal infections among critically ill adult COVID-19 patients: First experiences from the national centre in Hungary
por: Szabo, Balint Gergely, et al.
Publicado: (2021) -
Baricitinib vs tocilizumab treatment for hospitalized adult patients with severe COVID-19 and associated cytokine storm: a prospective, investigational, real-world study
por: Lakatos, Botond, et al.
Publicado: (2022) -
Clinical and microbiological characteristics and outcomes of community-acquired sepsis among adults: a single center, 1-year retrospective observational cohort study from Hungary
por: Szabo, Balint Gergely, et al.
Publicado: (2019)